Cancer biomarker discovery: Opportunities and pitfalls in analytical methods. - Wikidata - wikimedia - TriplyDB

Cancer biomarker discovery: Opportunities and pitfalls in analytical methods.

Cancer biomarker discovery: Opportunities and pitfalls in analytical methods.

http://www.wikidata.org/entity/Q37859348

about

Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations Evaluating the effects of preanalytical variables on the stability of the human plasma proteome Screening and functional analysis of a differential protein profile of human breast cancer Glycopeptide microarray for autoantibody detection in cancer.Global proteomics and metabolomics in cancer biomarker discovery.Identification of novel low molecular weight serum peptidome biomarkers for non-small cell lung cancer (NSCLC).Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma.Body fluid identification by mass spectrometry.Serum amino acid profiles and their alterations in colorectal cancer.Analysis of the Human Prostate-Specific Proteome Defined by Transcriptomics and Antibody-Based Profiling Identifies TMEM79 and ACOXL as Two Putative, Diagnostic Markers in Prostate Cancer Differential proteomic analysis of pathway biomarkers in human breast cancer by integrated bioinformatics.Protein target quantification decision tree.Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine Large scale non-targeted metabolomic profiling of serum by ultra performance liquid chromatography-mass spectrometry (UPLC-MS).Sarcosine as a potential prostate cancer biomarker--a review Metabolomic profiling identifies potential pathways involved in the interaction of iron homeostasis with glucose metabolism.The translation of lipid profiles to nutritional biomarkers in the study of infant metabolism.High-Throughput Analysis of Plasma Hybrid Markers for Early Detection of Cancers.Improving the outcomes: developing cancer therapeutics.Promoter CpG island methylation markers in colorectal cancer: the road ahead.Breast cancer biomarkers: proteomic discovery and translation to clinically relevant assays.Metabolomics for tumor marker discovery and identification based on chromatography-mass spectrometry.Cancer biomarker discovery: current status and future perspectives.Colorectal cancer biomarker discovery and validation using LC-MS/MS-based proteomics in blood: truth or dare?Systems biology meets -omic technologies: novel approaches to biomarker discovery and companion diagnostic development.Recent developments in circulating biomarkers in Parkinson's disease: the potential use of miRNAs in a clinical setting.Do the complementarities of electrokinetic and chromatographic procedures represent the "Swiss knife" in proteomic investigation? An overview of the literature in the past decade.Surface-activated chemical ionization-electrospray ionization source improves biomarker discovery with mass spectrometry.VIZR--an automated chemometric technique for metabolic profiling.Combining bioinformatics and MS-based proteomics: clinical implications.Detection of low frequency FGFR3 mutations in the urine of bladder cancer patients using next-generation deep sequencing.The 9th Siena meeting: from genome to proteome: open innovations.Stripping voltammetric detection of insulin at liquid-liquid microinterfaces in the presence of bovine albumin.Response biomarkers in neonatal intervention studies.The National Biomarker Development Alliance accelerating the translation of biomarkers to the clinic.Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco products.Genome-Scale Signatures of Gene Interaction from Compound Screens Predict Clinical Efficacy of Targeted Cancer Therapies.A universal immuno-PCR platform for comparative and ultrasensitive quantification of dual affinity-tagged proteins in complex matrices.Serum peptidome patterns for early screening of esophageal squamous cell carcinoma.Microfluidic chip coupled with modified paramagnetic particles for sarcosine isolation in urine.

P2860

Q28068009-050FC8C4-5771-4BD6-B893-C37AEE7BBB7C Q30372676-464E7B8D-86B5-4E3F-903B-C02EB1332A5B Q33727501-C7E33BDA-E2DA-4476-9353-1E6F222FE708 Q33983835-E175550D-864F-4602-B348-0CF2573E5035 Q34079038-E22D1111-2906-4DD7-9AA8-DD50ACC6C79E Q34281288-C39371E8-6158-4637-B158-E090359869D3 Q34450277-57A2FBB2-06A0-4254-B663-642BFED055DA Q34633625-0B7F9C5A-16EA-4C37-8FA0-0714F0E7FF9E Q34660782-EBB6E957-3D41-40AF-AA5A-628C757CE349 Q35735074-1581F0FC-C9DF-4ABC-904C-CCA8AEA5E5EE Q36403283-E3E707B2-1223-46D9-8513-263226078781 Q36582456-C521DBF9-2742-4342-B2DD-D0550B4EB474 Q36690546-C9CFCDDB-FF0B-4654-A081-BF30F15B9316 Q36804440-BD3D4A2E-6865-48C0-ABE5-7A81F314F9BD Q37091881-20643421-086C-4901-8D16-2C93C1E7D22E Q37570977-DBCD6E76-7D2F-4C4A-909E-680DA6CC7722 Q37610796-DD1FD6E2-53E3-47AC-A6A6-B356C3110AE8 Q37636426-6B27C1F9-1BC1-4EA8-9BDE-3622E69D7BBE Q37965556-49FC8A63-DFF0-4FBD-BE19-9A23A60832C7 Q37997086-E96E3746-54BC-4A78-AC3C-5470F7078216 Q38068925-6B605495-57E4-4A77-9943-7E3B2C4D0AB1 Q38103592-0D04C462-97B5-43AF-8A9D-E384DF0A89A8 Q38187679-5F9BBCA0-59AA-4981-A0B7-632BC2022261 Q38202166-2DB19F38-4A57-4E3E-B6A7-8AAF9B62796C Q38264304-9CF6071F-B1DD-41C9-B606-2EFDEEAF6FFF Q39010887-00D184E6-36AA-4EB4-9035-EE37F552F6DE Q39107333-CE6E67EE-D315-4C71-8E0D-D67F4E45AF44 Q40030151-207AFC16-D994-4F35-B300-78821A65BAE0 Q42612057-E7EC4961-F7F9-4B0A-93D9-F2A51A891710 Q42653805-DCDB0245-FB30-457B-B67E-C51244BA1AA0 Q42936880-2B7A3366-1928-4B06-BA92-489ED6E4EB69 Q43409807-8C48B05C-BAAD-4972-A2B3-3948232EDF8C Q44537946-E2AF7EAC-FD8D-4BF3-ACC2-60F9D325AAED Q47248009-2F83CFF5-D604-4FC8-8CE0-5DFCA507105F Q48065393-F7E4D672-ADE4-4098-A7A5-476B21C0AB01 Q49346082-7B24D84D-FE8E-4A4D-B95E-FD992C7DC75B Q50083199-1A81730E-FAF4-4965-A949-CC9F2CF96014 Q50490349-1C655E64-64DD-47DC-ADB4-B33DC389F6B1 Q51230642-C6A79851-9B1B-4DB0-B8C0-9EA3E9886FFA Q51530672-591C436D-19F1-4010-A5DB-51FC24C51ACC

P2860

Cancer biomarker discovery: Opportunities and pitfalls in analytical methods.

http://www.wikidata.org/entity/Q37859348

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 March 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cancer biomarker discovery: Opportunities and pitfalls in analytical methods.

@en

Cancer biomarker discovery: Opportunities and pitfalls in analytical methods.

@nl

type

label

Cancer biomarker discovery: Opportunities and pitfalls in analytical methods.

@en

Cancer biomarker discovery: Opportunities and pitfalls in analytical methods.

@nl

prefLabel

Cancer biomarker discovery: Opportunities and pitfalls in analytical methods.

@en

Cancer biomarker discovery: Opportunities and pitfalls in analytical methods.

@nl

P1433

Q37859348-899675B7-2CE6-4657-8BB5-724AC088B77B

P1476

Q37859348-5AE8C60F-017C-47B4-B581-320646598CFD

P2093

Q37859348-B8618D93-829D-4308-8A42-45A386555131

Q37859348-CBAC7E48-523D-4D6E-A9D8-1FE49F242D53

Q37859348-FF5902A1-3BD8-40C7-B449-EF297DF796CF

P2860

Q37859348-216D67CD-FE65-4CC0-B09F-9C80B6288D1C

Q37859348-2379E7DF-43BD-4801-834A-B554F8705FDC

Q37859348-24A1C063-757F-41A4-A4B1-2350A46032A6

Q37859348-2B8DDD99-173C-42C7-A861-8B6E23FC5D11

Q37859348-302DA831-B73F-4C23-BC26-32279C2ADCBF

Q37859348-3538F5BD-0CEF-494D-9BFA-9A5C823EAC67

Q37859348-392A286E-0D9F-4D22-BAB2-180730E58A17

Q37859348-399F1483-9913-4163-BE1B-B6075A3EE672

Q37859348-46C2C876-E04E-40F4-9E9E-8680946176D3

Q37859348-4BC358AC-A326-4831-A7EA-7CEE3E837414

P304

Q37859348-F7780D48-9EE7-47A1-814B-C3D69AA160ED

P31

Q37859348-3FBE34B1-B66F-4686-A3AC-F77D2E7B0B45

P356

Q37859348-08392B3F-4EB9-4522-8219-BECAC5E04295

P433

Q37859348-660B2016-422A-4792-BFB0-7EF1BE2A1D9D

P478

Q37859348-4AB004F4-C2F7-42ED-8A39-BAE158FA40F4

P577

Q37859348-917C6C37-5D82-4DB3-AFE8-15CB18F02241

P698

Q37859348-BAA16A47-F7C3-4E25-8730-9C6956FAF310

P921

Q37859348-2DBDFF05-A3F4-4CC9-A74B-257BFC1880DE

P356

P1433

Electrophoresis

P1476

Cancer biomarker discovery: Opportunities and pitfalls in analytical methods.

@en

P2093

Haleem J Issaq

http://www.w3.org/2001/XMLSchema#string

Timothy D Veenstra

http://www.w3.org/2001/XMLSchema#string

Timothy J Waybright

http://www.w3.org/2001/XMLSchema#string

P2860

Pathway analysis of kidney cancer using proteomics and metabolic profiling

An investigation into the human serum "interactome"

The human plasma proteome: a nonredundant list developed by combination of four separate sources

Combined blood/tissue analysis for cancer biomarker discovery: application to renal cell carcinoma

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

A model for random sampling and estimation of relative protein abundance in shotgun proteomics

'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data

Characterization of the low molecular weight human serum proteome.

Analysis of metabolomic data using support vector machines.

Urine-based assays for the detection of bladder cancer.

P304

967-975

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ELPS.201000588

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21449066

http://www.w3.org/2001/XMLSchema#string

P921